Dr. Leah Zhrebker, M.D.
What this data tells you about Dr. Zhrebker
Dr. Leah Zhrebker is a medical oncology in Bedford, TX, with 13 years in practice. Based on federal Medicare data, Dr. Zhrebker performed 32,325 Medicare services across 2,169 unique beneficiaries.
Between the years covered by Open Payments, Dr. Zhrebker received a total of $485 from 16 pharmaceutical and/or device companies across 25 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Zhrebker is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 10,400 | $43 | $137 |
| Anti-nausea injection (fosaprepitant) | 7,050 | $0 | $5 |
| Paclitaxel chemotherapy injection | 4,662 | $0 | $8 |
| Contrast dye for imaging (iodine-based) | 2,951 | $0 | $3 |
| Dexamethasone injection (steroid) | 1,202 | $0 | $1 |
| Comprehensive metabolic blood panel | 781 | $10 | $64 |
| Complete blood count (CBC) with differential | 762 | $8 | $36 |
| Blood draw (venipuncture) | 696 | $8 | $20 |
| Office visit, established patient (30-39 min) | 590 | $90 | $368 |
| Anti-nausea injection (Aloxi/palonosetron) | 510 | $1 | $114 |
| Injection, granisetron hydrochloride, 100 mcg | 400 | $0 | $24 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 241 | $23 | $157 |
| Administration of chemotherapy into vein, 1 hour or less | 195 | $101 | $707 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 144 | $20 | $128 |
| Iron level test | 128 | $6 | $27 |
| Iron binding capacity test | 128 | $8 | $35 |
| Ferritin level test (iron stores) | 127 | $13 | $60 |
| Injection, carboplatin, 50 mg | 115 | $2 | $300 |
| Injection, zoledronic acid, 1 mg | 110 | $7 | $431 |
| Lactate dehydrogenase (enzyme) level | 109 | $6 | $31 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 73 | $49 | $313 |
| Reticulated (young) platelet measurement | 72 | $35 | $143 |
| Administration of chemotherapy into vein, each additional hour | 69 | $22 | $161 |
| Injection, diphenhydramine hcl, up to 50 mg | 68 | $1 | $7 |
| Microscopic examination for white blood cells with manual cell count | 67 | $4 | $22 |
| Complete blood count (CBC), automated | 67 | $6 | $34 |
| Hospital follow-up visit, moderate complexity | 48 | $61 | $247 |
| Administration of additional new drug or substance into vein, 1 hour or less | 43 | $49 | $344 |
| Carcinoembryonic antigen (cea) protein level | 42 | $18 | $99 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 42 | $16 | $100 |
| Office visit, established patient, complex (40-54 min) | 42 | $128 | $496 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 41 | $85 | $657 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 36 | $26 | $145 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 35 | $1,114 | $4,802 |
| Unclassified drugs | 33 | $1 | $8 |
| Uric acid level test | 30 | $4 | $25 |
| Ct scan of chest with contrast | 29 | $56 | $821 |
| Drug injection, under skin or into muscle | 28 | $10 | $96 |
| Hospital follow-up visit, high complexity | 28 | $90 | $357 |
| Injection of additional new drug or substance into vein | 26 | $12 | $108 |
| Infusion, normal saline solution , 1000 cc | 26 | $2 | $19 |
| CT scan of abdomen and pelvis with contrast | 23 | $152 | $1,067 |
| New patient office visit (45-59 min) | 21 | $109 | $565 |
| Infusion into a vein for hydration, each additional hour | 20 | $10 | $75 |
| Initial hospital admission, moderate complexity | 15 | $101 | $470 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (83%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Zhrebker is a mixed practice specialist, with above-average Medicare volume (top 28% in TX), and low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Zhrebker experienced with pembrolizumab injection (keytruda)?
Does Dr. Zhrebker receive payments from pharmaceutical companies?
How do Dr. Zhrebker's costs compare to other medical oncologys in Bedford?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology